Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Dec 15:6:48.
doi: 10.1186/1471-2261-6-48.

Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease

P Michael Ho  1 , David J Magid, Frederick A Masoudi, David L McClure, John S Rumsfeld
Affiliations
Comparative Study

Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease

P Michael Ho et al. BMC Cardiovasc Disord. .

Abstract

Background: Patients with diabetes and ischemic heart disease (IHD) are at high risk for adverse cardiac outcomes. Clinical practice guidelines recommend multiple cardioprotective medications to reduce recurrent events. We evaluated the association between cardioprotective medication adherence and mortality among patients with diabetes and IHD.

Methods: In a retrospective cohort study of 3,998 patients with diabetes and IHD, we evaluated use of ACE inhibitors or angiotensin receptor blockers, beta-blockers, and statin medications. Receipt of cardioprotective medications was based on filled prescriptions. Medication adherence was calculated as the proportion of days covered (PDC) for filled prescriptions. The primary outcome of interest was all-cause mortality.

Results: The majority of patients (92.8%) received at least 1 cardioprotective medication. Patients receiving any medications had lower unadjusted mortality rates compared to patients not receiving any medications (7.9% vs. 11.5%; p = 0.03). In multivariable analysis, receipt of any cardioprotective medication remained associated with lower all-cause mortality (OR 0.65; 95% CI 0.43-0.99). Among patients receiving cardioprotective medications, the majority (80.3%) were adherent (PDC > or = 0.80). Adherent patients had lower unadjusted mortality rates (6.7% vs. 12.1%; p < 0.01). In multivariable analysis, medication adherence remained associated with lower all-cause mortality (OR 0.52; 95% CI 0.39-0.69) compared to non-adherence. In contrast, there was no mortality difference between patients receiving cardioprotective medications who were non-adherent compared to patients not receiving any medications (OR 1.01; 95% CI 0.64-1.61).

Conclusion: In conclusion, medication adherence is associated with improved outcomes among patients with diabetes and IHD. Quality improvement interventions are needed to increase medication adherence in order for patients to maximize the benefit of cardioprotective medications.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The association between receipt of cardioprotective medications, medication adherence and mortality.
See this image and copyright information in PMC

References

    1. Selby JV, Peng T, Karter AJ, Alexander M, Sidney S, Lian J, Arnold A, Pettitt D. High rates of co-occurrence of hypertension, elevated low-density lipoprotein cholesterol, and diabetes mellitus in a large managed care population. Am J Manag Care. 2004;10:163–70. - PubMed
    1. American Heart Association . Heart Disease and Stroke Statistics – 2006 Update. Dallas, Texas American Heart Association; 2006.
    1. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Jr, Fihn SD, Fraker TD, Jr, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV. ACC/AHA 2002 guidelines update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients With Chronic Stable Angina) 2002. - PubMed
    1. American Diabetes Association Standards of medical care in diabetes. Diabetes Care. 2005;28:S436. - PubMed
    1. World Health Organization Adherence to long-term therapies: evidence for action. 2003.

Publication types

MeSH terms

Substances

LinkOut - more resources